The CHEK2 c.1100delC germline mutation rarely contributes to breast cancer development in the Czech Republic
2005; Springer Science+Business Media; Volume: 90; Issue: 2 Linguagem: Inglês
10.1007/s10549-004-4023-8
ISSN1573-7217
AutoresZdeněk Kleibl, Jan Novotný, Drahomira Bezdickova, Radek Malı́k, Petra Kleiblová, Lenka Foretová, Luboš Petruželka, Denisa Ilenčíková, Petr Cinek, Petr Pohlreich,
Tópico(s)Breast Cancer Treatment Studies
Referência(s)